Welcome to our dedicated page for Wearable Devices SEC filings (Ticker: WLDSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) is a foreign private issuer that reports to the U.S. Securities and Exchange Commission primarily through Form 20-F and Form 6-K filings. On Stock Titan’s WLDSW SEC filings page, investors can review these regulatory documents alongside AI-generated summaries that clarify the key points in each report.
The company’s Form 6-K current reports often include details of capital-raising transactions, such as registered direct offerings of ordinary shares, pre-funded warrants, and ordinary warrants, as well as warrant inducement agreements. These filings typically describe purchase agreements, placement agency agreements, exercise prices, and registration commitments related to new securities. Other 6-Ks incorporate press releases about patents, product developments, and clinical or commercial milestones, making them an important source for understanding material events.
Wearable Devices also uses its SEC filings to file financial statements and management’s discussion and analysis for interim periods, and to update information about equity incentive plans and share reserves. Many of these reports are expressly incorporated by reference into existing registration statements on Form F-3 and Form S-8, which are also identified in the filings.
On this page, Stock Titan provides real-time access to new WLDSW filings from EDGAR, along with AI-powered explanations that break down complex legal and financial language into more accessible summaries. Users can quickly locate filings that relate to warrant terms, equity offerings, incentive plans, and other corporate actions, and can explore how these disclosures fit into the company’s broader strategy in AI-powered neural input wearables. This resource helps investors and researchers interpret the regulatory record of Wearable Devices Ltd. without reading every filing in full.
Wearable Devices Ltd. director Ilana Lurie filed an initial ownership report showing her equity stake in the company. She directly holds 37,500 Ordinary Shares. This amount includes 7,500 shares issuable from 2,500 restricted share units (RSUs) that begin vesting on October 10, 2026 and then in equal monthly installments through October 10, 2028, and 28,333 shares issuable from RSUs vesting in equal monthly installments of 833 shares through January 1, 2029, with each RSU representing one Ordinary Share.
She also holds a stock option covering 83 Ordinary Shares at an exercise price of 316.8000, which was granted on November 30, 2023, vests in monthly installments after an initial vesting on August 23, 2024, and expires on November 30, 2033.
Wearable Devices Ltd. director Nir Yaacov filed an initial insider ownership report on Form 3. The filing lists him as a director of the company but does not report any share transactions or derivative positions, indicating this is a baseline disclosure rather than a trading event.
Wearable Devices Ltd. Chief Financial Officer Mualem Alon filed an initial Form 3 reporting his existing equity position. He directly holds 52,083 Ordinary Shares and has stock options covering 417 shares at an exercise price of $0.7200 expiring on January 23, 2032 and 83 shares at $316.8000 expiring on November 30, 2033. Footnotes also describe RSU awards for 5,000 Ordinary Shares vesting monthly through September 10, 2026 and 37,778 Ordinary Shares vesting monthly through January 1, 2029, each RSU representing one Ordinary Share.
Wearable Devices Ltd. Chief Operating Officer Tamar Fleisher filed an initial ownership report showing direct holdings in the company’s ordinary shares and equity awards. The filing lists 23,667 Ordinary Shares, which include RSUs for 2,500 shares vesting in monthly installments of 417 shares through September 10, 2026 and RSUs for 16,056 shares vesting in monthly installments of 472 shares through January 1, 2029. Fleisher also holds stock options over 125 ordinary shares at an exercise price of 158.4000, expiring on December 15, 2032, and options over 63 ordinary shares at an exercise price of 316.8000, expiring on November 30, 2033. These entries reflect existing positions rather than new market purchases or sales.
Wearable Devices Ltd. reported full-year 2025 results showing early revenue growth but continued losses. Revenue rose to $647 thousand from $522 thousand, helped by a 28.5% increase in sales of its Mudra Link and Mudra Band gesture-control products.
The company remained unprofitable, with an operating loss of $8.3 million and a net loss of $8.1 million. During 2025 it raised approximately $24.4 million in gross proceeds from equity offerings, ending the year with a cash balance of $6.5 million and short-term deposits of $11.9 million, for total current assets of $19.5 million. Total liabilities fell to $1.4 million after repaying a convertible note, and shareholders’ equity increased to $18.6 million.
Wearable Devices Ltd. is carrying out a 1‑for‑3 reverse share split of its ordinary shares and publicly traded warrants. Every three existing shares or warrants will be consolidated into one, with warrant exercise prices adjusted proportionally.
The move aims to increase the share price to help regain compliance with Nasdaq’s $1.00 minimum bid requirement and protect the company’s continued listing on the Nasdaq Capital Market. After the split, issued and outstanding ordinary shares will be reduced from 10,593,227 to approximately 3,531,076, and publicly held warrants from 98,589 to approximately 32,863, while authorized capital remains at 500,000,000 shares.
The split, approved by shareholders and the board at a 1‑for‑3 ratio, will take effect for trading on a split‑adjusted basis when the market opens on March 11, 2026. Fractional positions will be rounded to the nearest whole share or warrant, and outstanding equity awards and plan reserves will be adjusted proportionally.
Wearable Devices Ltd. reported that its Board of Directors approved an increase in the number of ordinary shares reserved for its 2024 Global Equity Incentive Plan. The reserve rose by 1,431,713 shares, from 2,473,856 to 3,905,569 ordinary shares.
This change expands the pool of shares available for future equity-based awards to employees, directors, and other eligible participants under the plan. The report is also incorporated by reference into the company’s existing Form S-8 and Form F-3 registration statements.
Wearable Devices Ltd. held a special shareholder meeting where a quorum was reached after an adjournment and all seven proposals were approved. A key outcome was adoption of an amended and restated compensation policy for executives and directors.
The updated policy increases the chief executive officer’s maximum base salary and raises annual bonus caps. It also revises the mix between fixed and variable pay by role, expands equity-based compensation limits for office holders, and increases the maximum annual equity grants for directors. The detailed policy, dated September 2025, is attached as an exhibit and will govern salaries, bonuses, equity awards, change-of-control treatment and clawback mechanisms for the company’s office holders.
Wearable Devices Ltd. Schedule 13G shows Armistice Capital, LLC and Steven Boyd jointly report beneficial ownership of 619,818 ordinary shares, representing 9.99% of the class as of 12/31/2025. The shares are held directly by Armistice Capital Master Fund Ltd., for which Armistice Capital acts as investment manager and exercises voting and dispositive power under an Investment Management Agreement; the Master Fund disclaims beneficial ownership due to its inability to vote or dispose of the securities under that agreement. The joint filing is signed by Steven Boyd and dated 02/17/2026.
Wearable Devices Ltd. filed a Form 6-K highlighting a strategic product initiative and leadership appointment. The company plans to launch the Mudra Experience Studio, a developer platform that turns its neural input technology into a universal gesture language for extended reality (XR), mobile, desktop, and AI-powered applications.
The platform will offer production-ready SDKs, standardized gesture taxonomy, and integration with AI-driven development tools, aiming to let developers build once and deploy across Apple, Meta, Android XR, and desktop ecosystems. Wearable Devices opened a priority waitlist to support a 2026 rollout and reports strong early developer interest.
The company also appointed Ron Kaldes as Head of Growth, AI & Innovation to help drive the ai6 Labs and Mudra Experience Studio strategy, leveraging his background in consumer technology and AI consulting. The filing incorporates parts of this press release into existing S-8 and F-3 registration statements.